Trial Profile
Safety and efficacy of solifenacin succinate [VESIcare] for the treatment of overactive bladder in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 07 Dec 2015 New trial record